3.5.3.18	Renal Insufficiency, Chronic	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24125425&form=6&db=m	A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease.	causal interaction,unassigned	4,0	
3.5.3.18	Diabetes Mellitus, Type 2	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22558392&form=6&db=m	A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity.	causal interaction,therapeutic application,unassigned	4,4,0	
3.5.3.18	Insulin Resistance	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22558392&form=6&db=m	A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity.	causal interaction,therapeutic application,unassigned	4,4,0	
3.5.3.18	Coronary Artery Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31409409&form=6&db=m	A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.	causal interaction,diagnostic usage,unassigned	4,4,0	
3.5.3.18	Myocardial Infarction	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=31409409&form=6&db=m	A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients.	causal interaction,diagnostic usage,unassigned	4,4,0	
3.5.3.18	Carcinoma, Hepatocellular	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28741166&form=6&db=m	A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.	causal interaction,unassigned	3,0	
3.5.3.18	Neoplasms	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=28741166&form=6&db=m	A new key player in VEGF-dependent angiogenesis in human hepatocellular carcinoma: dimethylarginine dimethylaminohydrolase 1.	causal interaction,unassigned	3,0	
3.5.3.18	Coronary Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20167924&form=6&db=m	A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease.	causal interaction,ongoing research,therapeutic application,unassigned	4,4,1,0	
3.5.3.18	Stroke	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20167924&form=6&db=m	A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease.	causal interaction,ongoing research,therapeutic application,unassigned	4,4,1,0	
3.5.3.18	Thrombosis	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=20167924&form=6&db=m	A novel loss-of-function DDAH1 promoter polymorphism is associated with increased susceptibility to thrombosis stroke and coronary heart disease.	causal interaction,ongoing research,therapeutic application,unassigned	4,4,1,0